November 12, 2020 by Chain Drug Review
Alex Azar, COVID-19 vaccines, HHS
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — To maximize access to COVID-19 vaccines for all Americans, the U.S. Department of Health and Human Services (HHS) today announced the U.S. government’s partnerships with large chain pharmacies and networks that represent independent pharmacies and regional chains. Through the partnership with pharmacy chains, this program covers approximately 60% of pharmacies throughout the 50
August 27, 2020 by Chain Drug Review
Alex Azar, COVID-19, NACDS, Steven Anderson, vaccines
Leading Headlines, Pharmacy

ARLINGTON, Va. — Continuing proactive engagement with the nation’s governors and state executive teams that has remained a priority throughout the pandemic, NACDS this week urged states to take actions that will help ensure patients have ready access to vaccines from their trusted pharmacies and pharmacists. NACDS is urging states to act in response to the
August 19, 2020 by Chain Drug Review
Alex Azar, COVID-19, HHS
Leading Headlines, Pharmacy

WASHINGTON — The U.S. Department of Health and Human Services (HHS) issued a third amendment – PDF to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to increase access to lifesaving childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children across the United States return to daycare, preschool and school.
July 29, 2020 by Chain Drug Review
Alex Azar, COVID-19, Health Mart
Leading Headlines, Pharmacy

DALLAS — Secretary of Health and Human Services Alex Azar visited ReNue Rx, a Health Mart pharmacy, located at 2701 South Hampton Road today to recognize the meaningful work pharmacists are contributing to the fight against COVID-19 through test collection. More than 140 Health Mart pharmacies across 40 states are active in the eTrueNorth and Department of
May 4, 2020 by Chain Drug Review
Alex Azar, COVID-19, FDA, Remdesivir
Leading Headlines, Pharmacy

WASHINGTON — On Friday, the U.S. Food and Drug Administration issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease. While there is limited information known about the safety and effectiveness of using remdesivir to treat people in the
March 26, 2020 by Chain Drug Review
Alex Azar, COVID-19, NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy

WASHINGTON — NACDS this week praised recommendations by the Trump Administration to state governors on how to empower healthcare professionals to meet Americans’ needs amid COVID-19. NACDS urged the Administration and the states to remove more barriers to assure pharmacies and pharmacists are fully ready for the escalating demands of the pandemic. In a letter to the
January 3, 2020 by Chain Drug Review
Alex Azar, Dr. Stephen Hahn, e-cigarette products that appeal to kids, Food and Drug Administration (FDA), including fruit and mint flavors
Leading Headlines

SILVER SPRING, Md. — Amid the epidemic levels of youth use of e-cigarettes and the popularity of certain products among children, the U.S. Food and Drug Administration has issued a policy prioritizing enforcement against certain unauthorized flavored e-cigarette products that appeal to kids, including fruit and mint flavors. Under this policy, companies that do not cease
February 18, 2019 by Chain Drug Review
Alex Azar, NACDS
February 18, 2019, News

WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association (NCPA) have praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the secretary for concepts in the Centers for Medicare and Medicaid Services’ (CMS’) proposed rule, Modernizing Part D and Medicare Advantage to
February 5, 2019 by Chain Drug Review
Alex Azar, B. Douglas Hoey, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, National Association of Chain Drug Stores (NACDS, National Community Pharmacists Association (NCPA), Steven Anderson
Leading Headlines, Pharmacy

WASHINGTON — The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) Tuesday praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the Secretary for concepts in the Centers for Medicare & Medicaid Services’ (CMS) proposed rule, Modernizing Part D and Medicare Advantage
January 2, 2019 by Chain Drug Review
Alex Azar, allergen, drug prices, GlaxoSmithKline, HHS
Featured Articles, Leading Headlines, Pharmacy, Supplier News

NEW YORK — Drugmakers are increasing the price of hundreds of drugs by an average of more than 6%, according to a new analysis by Rx Savings Solutions. With pressure on the pharmaceutical industry to hold down prices mounting, many of the increases are relatively small. But some generics are seeing steep hikes, and overall
October 12, 2018 by Chain Drug Review
“gag clause” ban, Alex Azar, and S. 2554, Karry La Violette, NCPA, Paul Mango, S. 2553, the Know the Lowest Price Act of 2018, the Patient Right to Know Drug Prices Act
Leading Headlines, Pharmacy

PITTSBURGH – U.S. Department of Health and Human Services secretary Alex Azar and Paul Mango, chief principal deputy administrator and chief of staff in the Centers for Medicare and Medicaid Services’ Office of the Administrator, today visited Spartan Pharmacy in Pittsburgh as part of ongoing efforts to highlight President Trump’s signing into law legislation to ban
May 11, 2018 by Chain Drug Review
Alex Azar, American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, drug pricing, NACDS
Leading Headlines, Pharmacy

ARLINGTON, Va. — NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it. In short, we anticipate learning more details in the coming days, and NACDS will analyze the Administration’s proposals and provide
April 20, 2018 by Chain Drug Review
Alex Azar, direct and indirect remuneration, Medicare Part D, National Association of Chain Drug Stores, Steven Anderson
Leading Headlines, Pharmacy

ARLINGTON, Va. — In the growing effort to achieve pro-patient and pro-pharmacy reforms of direct and indirect remuneration (DIR) fees in Medicare Part D, the National Association of Chain Drug Stores today hailed a letter to Health and Human Services Secretary Alex Azar signed by 50 members of the U.S. House of Representatives and led
March 19, 2018 by Chain Drug Review
Alex Azar, Every Prescription Conveyed Securely Act, Kevin Nicholson, Melania Trump, NACDS, National Association of Chain Drug Stores, opioid abuse, President Donald Trump, Steve Anderson, White House Opioid Summit
2018, Issue 03-19-2018, Issues, News

ARLINGTON, Va. — The National Association of Chain Drug Stores took part in this month’s White House Opioid Summit as it continues to give retail pharmacy’s take on how to combat the opioid abuse epidemic. Kevin Nicholson, vice president of public policy and regulatory affairs at NACDS, represented the association at the March 1 event,